Make your money go further for just 25p per day

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

17/11/2020 · AdEPT Technology (ADT)  · Craneware PLC (CRW)  · dotDigital Group PLC (DOTD)  · Eagle Eye Solutions Group PLC (EYE)  · IDOX (IDOX)  · Scapa Group (SCPA) 

AIM Coronavirus Investment Ideas UK

dotDigital connecting data channels diagram

Quality is worth paying a premium for and a company covered here has many of the attributes of an extremely good business. Others look more challenged, as you can discover here.


AdEPT: results underwhelm

AdEPT Technology Group (LON: ADT), a leading provider of managed IT services announced results for the six months ended 30 September 2020. While the numbers have held up reasonably well, we were actually anticipating somewhat better over a time when many businesses meaningfully increased expenditure on IT to support operations and remote working.

Revenue fell 7.6% to £28.5m and adjusted profit after tax was 20.5% lower at £3.1m. The statutory results were a…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world

REGISTER FREE

Become a Champion Investor for just £90 a year.
 
 

START FREE TRIAL

More on AdEPT Technology

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

17/11/2020 · Company Insights

Quality is worth paying a premium for and a company covered here has many of the…


Coronavirus impact: 14 July - plenty of updates and a bizarre response from Manolete

14/07/2020 · Company Insights

Plenty of results and updates today, including a robust response from Manolete Partners, an insolvency litigation financing firm,…


More on Craneware PLC

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

17/11/2020 · Company Insights

Quality is worth paying a premium for and a company covered here has many of the…


Coronavirus impact: 21 Sept - mixed bag of results to start the week

21/09/2020 · Company Insights

Full year results from a provider of software solutions to the US healthcare sector were the…


More on dotDigital Group PLC

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

17/11/2020 · Company Insights

Quality is worth paying a premium for and a company covered here has many of the…


Coronavirus impact: 20 Oct - another strong update from this digital winner

20/10/2020 · Company Insights

Another day of impressive updates from several fast-growing AIM companies covered here. Despite the strong performance…


More on Eagle Eye Solutions Group PLC

Electric Vehicle charging offers potential of juicy returns

11/12/2020 · Company Insights

Full year results from a provider of essential infrastructure service covered here highlight the growth potential…


Vaccine countdown update: 17 Nov (2) - quality is worth the premium

17/11/2020 · Company Insights

Quality is worth paying a premium for and a company covered here has many of the…


More on IDOX

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

17/11/2020 · Company Insights

Quality is worth paying a premium for and a company covered here has many of the…


Coronavirus impact: 15 June - fantastic results but why bother with the stock market

15/06/2020 · Company Insights

A company’s stock market listing generally implies an ability to freely buy and sell its shares.…


More on Scapa Group

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

17/11/2020 · Company Insights

Quality is worth paying a premium for and a company covered here has many of the…


Coronavirus impact: 13 Oct - we aren’t impressed with the antics of some

13/10/2020 · Company Insights

It has taken a long time coming, but a developer of medical devices covered here, finally…


More Company Insights

Pressure Tech: keep an eye on the hydrogen story

Blue Prism tumbles but others impress

More on AdEPT Technology

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

Coronavirus impact: 14 July - plenty of updates and a bizarre response from Manolete

Coronavirus impact: 2 April - dividend commitments

More than Money: Phil Race

More on Craneware PLC

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

Coronavirus impact: 21 Sept - mixed bag of results to start the week

Coronavirus impact: 12 Aug - ASOS marches on but 7digital is pick of the day

Coronavirus impact: 8 July - Boohoo shares continue to tumble, more resilience elsewhere

More on dotDigital Group PLC

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

Coronavirus impact: 20 Oct - another strong update from this digital winner

Coronavirus impact: 29 Sept - more terrific news for this Covid tester and the UK population

Coronavirus impact: 23 July - anti viral boost sees shares of this small company soar

More on Eagle Eye Solutions Group PLC

Electric Vehicle charging offers potential of juicy returns

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

Coronavirus impact: 16 Sept - keep an eagle eye on this

Coronavirus impact: 16 July - fabulous results from a modestly valued stockbroker

More on IDOX

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

Coronavirus impact: 15 June - fantastic results but why bother with the stock market

Coronavirus impact: 19 May - reliability on offer from some highly rated companies

IDOX (AIM: IDOX) – mildly disappointing results, but remaining highly cash generative.

More on Scapa Group

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

Coronavirus impact: 13 Oct - we aren’t impressed with the antics of some

Coronavirus impact: 23 June - a bonkers valuation of the week is even worse than we expected

Scapa Group - Bonkers valuation of the week

More Company Insights

Pressure Tech: keep an eye on the hydrogen story
Blue Prism tumbles but others impress
Best of the Best: amazing results, but it’s easier to win their competitions than buy the shares